| [1] |
LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu.
Advances in the mechanism of action of the ring finger proteins family in breast cancer
[J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
|
| [2] |
ZHANG Yanchi, SHI Junqi, ZHANG Yijun, DUAN Jiawen, LIU Jinyu, ZHANG Liyan, LIANG Wanping.
Advances in synergistic therapies targeting metabolic mechanisms and the immune microenvironment in breast cancer
[J]. Basic & Clinical Medicine, 2025, 45(12): 1662-1667.
|
| [3] |
JIN Xiaoxia, LIU Yushan, HU Jiping, ZHU Xinghua.
Expression of COA6 in breast cancer and its correlation with tumor immune cell infiltration
[J]. Basic & Clinical Medicine, 2025, 45(6): 755-761.
|
| [4] |
ZHANG Ke, LU Jiangning, SUN Lixin, YU Long, SUN Lichao, RAN Yuliang.
TOMM40L promotes proliferation and migration of triple negative breast cancer cells and correlates with poor prognosis
[J]. Basic & Clinical Medicine, 2025, 45(5): 575-582.
|
| [5] |
XIA Yujia, YANG Zhenli, DAI Di, LIU Yuqin.
Culture and characterization of breast cancer organoids
[J]. Basic & Clinical Medicine, 2024, 44(9): 1223-1228.
|
| [6] |
LU Kai, LU Jianju, GUO Wenli, HUANG Jianqi, LI Zhihua.
lncRNA VIM-AS5 expression and its effect on proliferation and migration of human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2024, 44(4): 447-453.
|
| [7] |
ZHANG Zhongwen, ZHAO Rui, ZHANG Haolong, YANG Yuting, BAI Jinxia, ZHANG Haoling WANG Wei.
Research progress on P2X7 receptor in cancer pain
[J]. Basic & Clinical Medicine, 2024, 44(3): 389-392.
|
| [8] |
Yiheliman·MAIMAITI, CAO Yanzhen, WANG Cuicui, YUE Na, LIANG Liping.
Correlation between PIK3CA mutation and clinicopathological features and prognosis of breast cancer
[J]. Basic & Clinical Medicine, 2024, 44(3): 303-307.
|
| [9] |
LI Jiangli, SUN Jing, TANG Yijun, GUO Junlan, CHEN Bo, GUO Shengnan.
Circ-DDX5 inhibits the proliferation and invasion of human breast cancer cell lines by targeting miR-3940
[J]. Basic & Clinical Medicine, 2024, 44(1): 1-7.
|
| [10] |
ZHANG Xiao-lei, LIU Jing, LI Chao-ping.
Circ_0032821 is involved in sorafenib's inhibition of the proliferation, migration and invasion of breast cancer cell line T47D
[J]. Basic & Clinical Medicine, 2022, 42(9): 1350-1354.
|
| [11] |
ZHOU Mei-cen, LAN Ling, DENG Wei.
Advances of research on the function of RNA binding proteins in the pathogenesis of thyroid carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(8): 1306-1309.
|
| [12] |
WANG Zi-yuan, DUAN Zhao-jun, LUO Yun-ping.
Establishment and validation of lung-specific metastatic cell subline of mouse breast cancer
[J]. Basic & Clinical Medicine, 2022, 42(7): 1083-1091.
|
| [13] |
XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin.
Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2022, 42(5): 758-762.
|
| [14] |
HE Xiao, HU Wei-jie, LYU Wen-chang, REN Yu-ping, WU Min, WU Yi-ping, ZHANG Qi.
Advances on the roles of circular RNA in breast cancer
[J]. Basic & Clinical Medicine, 2022, 42(3): 507-511.
|
| [15] |
XIONG Yu-yuan, CHEN De-jie, MENG Lin, YAN Shan.
TLK2 promotes the proliferation, migration and invasion of human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2021, 41(8): 1156-1162.
|